Dual regulation of the epidermal growth factor family of growth factors in breast cancer by sex steroids and protein kinase C

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 1-2, 1996, Pages 1-11

  Martínez Lacaci, Isabel ^a   Dickson, Robert B ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR ALPHA;

BREAST CANCER; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; MALE; PROSTATE CANCER; REVIEW;

BREAST NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; PHORBOL ESTERS; PROSTATIC NEOPLASMS; PROTEIN KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STEROIDS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0029870667     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00245-6     Document Type: Review

References (145)

1. Marshall E.: Search for a killer: focus shifts from fat to hormones. Science 259 (1993) 618-621.
2. Kelsey J. L. and Berkowitz G. S.: Breast cancer epidemiology. Cancer Res. 48 (1988) 5615-5623.
3. Kelsey J. L.: A review of the epidemiology of breast cancer. Epidemiol. Rev. 1 (1979) 74-109.
4. Henderson B. E., Ross R. K. and Pike M. C.: Hormonal chemoprevention of cancer in women. Science 259 (1993) 633-638.
5. Ojeda S.R.: Female reproductive function. In Textbook of Endocrine Physiology (Edited by J. E. Griffin and S. R. Ojeda). Oxford University Press, New York (1988) pp. 129-164.
6. Beatson G. T.: On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 2 (1896) 162-165.
7. Dickson R. B. and Lippman M. E.: The molecular basis of breast cancer. In The Molecular Basis of Cancer (Edited by I. Mendelsohn, P. Howley, L. Liotta and M. Israrel). W. B. Saunders Co., Philadelphia (1995) pp. 358-386.
8. Dickson R. B., Bano M., Johnson M. D., Shi Y. E., Martínez-Lacaci I., Amundadottir L. T., Ziff B. and Kurebayashi J.: Steroid regulation of growth factors and protooncogenes in the normal and malignant mammary gland. In Protooncogenes and Growth Factors in Steroid Hormone Induced Growth and Differentiation (Edited by S. A. Khan and G. M. Stancel). CRC Press, Boca Raton (1994) pp. 143-174.
9. Dickson R. B., Johnson M. D., Bano M., Shi, E., Kurebayashi J., Ziff B., Martínez-Lacaci I., Amundadottir L. T. and Lippman M. E.: Growth factors in breast cancer: mitogenesis to transformation. J. Steroid Biochem. Molec. Biol. 43 (1992) 69-78.
10. Freiss G., Prébois C. and Vignon F.: Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms. Breast Cancer Res. Treat. 27 (1993) 57-68.
11. Goustin A. S., Leof E. B., Shipley G. D. and Moses H. L.: Growth factors and cancer. Cancer Res. 46 (1986) 1015-1029.
12. Sporn M. I. and Roberts A.: Autocrine growth factors and cancer. Nature 313 (1985) 745-747.
13. Gronemeyer H.: Transcription activation by estrogen and progesterone receptors. A. Rev. Genet. 25 (1991) 89-123.
14. Yamamoto K. R.: Steroid receptor regulated transcription of specific genes and gene networks. A. Rev. Genet. 19 (1985) 209-252.
15. Gronemeyer H.: Control of transcription activation by steroid hormone receptors. FASEB J. 6 (1992) 2524-2529.
16. Evans R. M.: The steroid and thyroid hormone receptor superfamiliy. Science 240 (1988) 889-895.
17. Kumar V., Green S., Stack G., Berry M., Jin J. R. and Chambon P.: Functional domains of the human estrogen receptor. Cell 51 (1987) 941-951.
18. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E. and Chambon P.: The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59 (1989) 477-487.
19. Kumar V., Green S., Staub A. and Chambon, P.: Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J. 5 (1986) 2231-2236.
20. Evans R. M. and Hollenberg S. M.: Zinc fingers: guilt by association. Cell 52 (1988) 1-3.
21. Catelli M. G., Binart N., Jung-Testas I., Renoir J. M., Baulieu E. E., Feramisco J. R. and Welch W. J: The common 90-kd protein component of non-transformed '8S' steroid receptors is a heat-shock protein. EMBO J. 4 (1985) 3131-3135.
22. Sánchez E. R., Toft D. O., Schlessinger M. J. and Pratt W. B.: Evidence that the 90-kDa phosphoprotein associated with the untransformed L-cell glucocorticoid receptor is a murine heatshock protein. J. Biol. Chem. 260 (1985) 12,398-12,401.
23. Baulieu E. E.: Steroid hormone antagonists at the receptor level: a role for the heat-shock protein MW 90,000 (hsp 90) J. Cell. Biochem. 35 (1987) 161-174.
24. Kumar V. and Chambon P.: The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55 (1988) 145-156.
25. Webster N. J. G., Green S., Jin J. R. and Chambon P.: The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54 (1988) 199-207.
26. Beato M.: Transcriptional control by nuclear receptors. FASEB J. 5 (1991) 2044-2051.
27. Ortí E, Bodwell J. E. and Munck A.: Phosphorylation of steroid receptors. Endocr. Rev. 13 (1992) 105-128.
28. Auricchio F.: Phosphorylation of steroid receptors. J. Steroid. Biochem. 32 (1989) 613-622.
29. Denton R. R., Koszewski N. J. and Notides A. C.: Estrogen receptor phosphorylation. J. Biol. Chem. 267 (1992) 7263-7268.
30. Le Goff P., Montano M. M., Schodin D. J. and Katzenellenbogen B. S.: Phosphorylation of the human estrogen receptor. J. Biol. Chem. 269 (1994) 4458-4466.
31. Lahooti H., White R., Danielian P. S. and Parker M. G.: Characterization of ligand-dependent phsophorylation of the estrogen receptor. Molec. Endocr. 8 (1994) 182-188.
32. Denner L. A., Weigel N. L., Maxwell B. L., Schrader W. T. and O'Malley B.: Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250 (1990) 1740-1743.
33. Saceda M., Lippman M. E., Chambon P., Lindsey R. K., Ponglikitmongkol M., Puente M. and Martin M. B.: Regulation of the estrogen receptor in MCF-7 cells by estradiol. Molec. Endocr. 2 (1988) 1157-1162.
34. Saceda M., Knabbe C., Dickson R. B., Lippman M. E., Bronzert D., Lindsey R. K., Gottardis M. M. and Martin M. B.: Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem. 266 (1991) 17,809-17,814.
35. Ignar-Trowbridge D. M., Nelson K. H., Bidwell M. C., Curtis S. W., Washburn T. F., McLachlan J. A. and Korach K. S.: Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natn. Acad. Sci. U.S.A. 89 (1992) 4658-4662.
36. Berthois Y., Dong X. F. and Martin P. M.: Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7. Biochem. Biophys. Res. Commun. 159 (1989) 126-131.
37. Rao K. V. S. and Fox C. F.: Epidermal growth factor stimulates tyrosine phosphorylation of human glucocorticoid receptor in cultured cells. Biochem. Biophys. Res. Commun. 144 (1987) 512-519.
38. Hata A., Akita Y., Konno Y., Suzuki K. and Ohno S.: Direct evidence that the kinase activity of protein kinase C is involved in transcriptional activation through a TPA-responsive element. FEBS Lett. 252 (1989) 144-146.
39. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P. and Karin M.: Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49 (1987) 729-739.
40. Imagawa M., Chiu R. and Karin M.: Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51 (1987) 251-260.
41. Nishizuka Y.: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 (1992) 607-614.
42. O'Brian C. A. and Ward N. E.: Biology of the protein kinase C family. Cancer and Metastasis Rev. 8 (1989) 199-214.
43. Nishizuka Y.: The role of protein kinase C in cell surface signal transduction. Nature 308 (1984) 693-698.
44. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U. and Nishizuka Y.: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257 (1982) 7847-7851.
45. Kishimoto A., Takai Y., Kaibuchi K., Sano K., Kikkawa U. and Nishizuka Y.: Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phospholipid turnover. J. Biol. Chem. 255 (1980) 2273-2276.
46. House C. and Kemp, B. E.: Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238 (1987) 1726-1728.
47. Ono Y., Fujii T., Igarashi K., Kuno T., Tanaka C., Kikkawa U. and Nishizuka Y.: Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc. Natn. Acad. Sci. U.S.A. 86 (1989) 4868-4871.
48. Gschwendt M., Kittstein W. and Marks F.: Protein kinase C activation by phorbol esters: do cysteine-rich regions and pseudosubstrate motifs play a role? Trends Biochem. Sci. 16 (1991) 167-169.
49. Kishimoto A., Mikawa K., Hashimoto K., Yasuda, I., Tanaka S. -I., Tominaga M., Kuroda T. and Nishizuka Y.: Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J. Biol. Chem. 264 (1989) 4088-4092.
50. Flint A. J., Paladini R. D. and Koshland D. E.: Autophosphorylation of protein kinase C at three separated regions of its primary sequence. Science 249 (1990) 408-411.
51. Mizuta K., Hashimoto E. and Yamamura H.: Proteolytic activation of protein kinase C by membrane-bound protease in rat liver plasma membrane. Biochem. Biophys. Res. Commun. 131 (1985) 1262-1268.
52. Olson E. N., Burgess, R. and Staudinger J.: Protein kinase C as a transducer of nuclear signals. Cell Growth Diff. 4 (1993) 699-705.
53. 2+-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors. Int. J. Cancer 40 (1987) 344-348.
54. Schüle R. and Evans R. M.: Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet. 7 (1991) 377-381.
55. Pfahl M.: Nuclear receptor / AP-1 interaction. Endocrine Rev. 14 (1993) 651-658.
56. Gaub M. -P., Bellard M., Scheuer I., Chambon P. and Sassone-Corsi P.: Activation of the ovoalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63 (1990) 1267-1276.
57. Tzukerman M., Zhang X. -K. and Pfahl M.: Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetrade-canoylphorbol-13-acetate: a molecular analysis. Molec. Endocr. 5 (1991) 1983-1992.
58. Doucas V., Spyrou G. and Yaniv M.: Unregulated expression of c-jun or c-fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. EMBO J. 10 (1991) 2237-2245.
59. Philips A., Chalbos D. and Rochefort H.: Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF-7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem. 268 (1993) 14,103-14,108.
60. Webb P., López G. N., Uht R. M. and Kushner P. J.: Tamoxifen activation of the estrogen receptor / AP-1 pathway potential origin for the cell-specific estrogen-like effects of antiestrogens. Molec. Endocr. 9 (1995) 443-456.
61. Migliaccio S., Wetsel W. L., Fox W. M., Washburn T. F. and Korach K. S.: Endogenous protein kinase-C activation in osteoblast-like cells modulate responsiveness to estrogen and estrogen receptor levels. Molec. Endocr. 7 (1993) 1133-1143.
62. Freter C. E., Lippman M. E., Cheville A., Zinn S. and Gelmann E. P.: Alterations in phosphoinositide metabolism associated with 17-β-estradiol and growth factor treatment on MCF-7 breast cancer cells. Molec. Endocr. 2 (1988) 159-166.
63. Cho H. and Katzenellenbogen B. S.: Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Molec. Endocr. 7 (1993) 441-452.
64. Yarden Y and Ullrich A.: Growth factor receptor tyrosine kinases. A. Rev. Biochem. 57 (1988) 443-478.
65. Lin C. R., Chen W. S., Lazar C. W., Carpenter C. D., Gill G. N., Evans R. M. and Rosenfeld M. G.: Protein kinase C phosphorylation at Thr 654 of the unocuppied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms. Cell 44 (1986) 839-848.
66. Ullrich A. and Schlessinger J.: Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212.
67. Rajkumar T. and Gullick W. J.: The type I growth factor receptors in human breast cancer. Breast Cancer Res. Treat. 29 (1994) 3-9.
68. King C. R., Borrello I., Bellot F., Comoglio P. and Schlessinger J.: EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3. EMBO J. 7 (1988) 1647-1651.
69. Goldman R., Ben-Levy R., Peles E. and Yarden Y.: Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29 (1990) 11,024-11,028.
70. Kokai Y., Myers J. N., Wada T., Brown V. I., LeVea C. M., Davis J. G., Dobashi K. and Greene M. I.: Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58 (1989) 287-292.
71. Dougall W. C., Qian X. and Greene M. I.: Interaction of the neu / p 185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy. J. Cell. Biochem. 53 (1993) 61-73.
72. Wada T., Qian X. and Greene M. I.: Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61 (1990) 1339-1347.
73. erbB4. Nature 366 (1993) 473-475.
74. Sliwkowski M. X., Schaefer G., Akita R. W., Lofgren J. A., Fitzpatrick V. D., Nuijens A., Fendly B. M., Cerione R. A., Vandlen R. L. and Carraway K. L.. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 269 (1994) 14,661-14,665.
75. Carraway K. L. III and Cantley L. C.: A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78 (1994) 5-8.
76. Chrysogelos S. A. and Dickson R. B.: EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res. Treat. 29 (1994) 29-40.
77. Mukku V. R. and Stancel G. M.: Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem. 260 (1985) 9820-9824.
78. Lingham R. B., Stancel G. M. and Loose-Mitchell D. S.: Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Molec. Endocr. 2 (1988) 230-235.
79. Murphy L. C., Murphy L. J. and Shiu R. P. C.: Progestin regulation of EGR-receptor mRNA accumulation in T47D human breast cancer cells. Biochem. Biophys. Res. Commun. 150 (1988) 192-196.
80. Clark A. J. L., Ishii S., Richert N., Merlino G. T. and Pastan I.: Epidermal growth factor regulates the expression of its own receptor. Proc. Natn. Acad. Sci. U.S.A. 82 (1985) 8374-8378.
81. Kudlow J. E., Cheung C. -Y. M.and Bjorge J. D.: Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line. J. Biol. Chem. 261 (1986) 4134-4138.
82. Fernández-Pol J. A., Klos D. J. and Hamilton P. D.: Modulation of transforming growth factor alpha-dependent expression of epidermal growth factor receptor gene by transforming growth factor beta, triiodothyronine, and retinoic acid. J. Cell Biochem. 41 (1989) 159-170.
83. Bjorge J. D. and Kudlow J. E. : Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. J. Biol. Chem. 262 (1987) 6615-6622.
84. Cohen S.: Isolation of a mouse submaxillary gland protein accelerating incisor eruption an eyelid opening in the new-born animal. J. Biol. Chem. 237 (1962) 1555-1562.
85. Gregory H.: Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 257 (1975) 325-327.
86. DiAugustine R. P.: The epidermal growth factor family in the mammary gland and other target organs for ovarian steroids. In Mammary Tumorigenesis and Malignant Progression (Edited by R. B. Dickson and M. E. Lippman). Kluwer Academic Publishers, Boston (1994) pp. 131-160.
87. Mroczkowski B., Reich M., Chen K., Bell G. I. and Cohen S.: Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity. Molec. Cell Biol. 9 (1989) 2771-2778.
88. Murphy L. C., Dotzlaw H., Wong M. S. J., Miller T., Mrockowski B., Gong Y. and Murphy L. J.: Epidermal growth factor: receptor and ligand expression in human breast cancer. Sem. Cancer Biol. 1 (1990) 305-315.
89. Murphy L. C., Murphy L. J., Dubik D., Bell G. I. and Shiu R. P. C.: Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Cancer Res. 48 (1988) 4555-4560.
90. Taketani Y. and Oka T.: Biological action of epidermal growth factor and its functional receptors in human mammary epithelial cells Proc. Natn. Acad. Sci. U.S.A. 80 (1983) 2647-2650.
91. Stampfer M. R.: Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Meth. 9 (1985) 107-115.
92. Osborne C. K., Hamilton B., Titus G. and Livingston R. B.: Epidermal growth factor stimulation of human breast cancer cells in culture. Cancer Res. 40 (1980) 2361-2366.
93. Imai Y., Leung C. K. H., Friesen H. G. and Shiu R. P. C.: Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long term tissue culture. Cancer Res. 42 (1982) 4394-4398.
94. Carpenter G.: Epidermal growth factor is a major growth-promoting agent in human milk. Science 210 (1980) 198-199.
95. Vonderhaar B. K.: Regulation of development of the normal mammary gland by hormones and growth factors. In Breast Cancer: Cellular and Molecular Biology (Edited by M. E. Lippman and R. B. Dickson), Kluwer Press, MA (1988) pp. 251-266.
96. Oka T., Tsutsumi O., Kurachi H. and Okamoto S.: The role of epidermal growth factor in normal and neoplastic growth of mouse mammary epithelial cells. In Breast Cancer: Cellular and Molecular Biology (Edited by M. E. Lippman and R. B. Dickson). Kluwer Press, MA (1988) pp. 343-362.
97. Okamoto S. and Oka T.: Evidence for physiological function of epidermal growth factor: progestational sialoadenectomy of mice decrease milk production and increases offspring mortality during lacatation period. Proc. Natn. Acad. Sci. U.S.A. 81 (1984) 6059-6063.
98. Tsutsumi O., Tsutsumi A. and Oka T.: Importance of epidermal growth factor in implantation and growth of mouse mammary tumor in female mice. Cancer Res. 47 (1987) 4651-4653.
99. Dotzlaw H., Miller T., Karvelas J. and Murphy L. C.: Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res. 50 (1990) 4204-4208.
100. Massagué J.: Transforming growth factor-α. J. Biol. Chem. 265 (1990) 21,393-21,396.
101. Bates S. E., Davidson N. E., Valverius E. M., Freter C. E., Dickson R. B., Tam J. P., Kudlow J. E., Lippman M. E. and Salomon D. S.: Expression of transforming growth factor-α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Molec. Endocr. 2 (1988) 543-555.
102. Saeki T., Cristiano A., Lynch M. J., Brattain M., Kim N., Normanno N., Kenney N., Ciardiello F. and Salomon D. S.: Regulation by estrogen through the 5′-flanking region of the transforming growth factor-α gene. Molec. Endocr. 5 (1991) 1955-1963.
103. Murphy L. C. and Dotzlaw H.: Regulation of transforming growth factor-α and transforming growth factor-β messenger ribonuleic acid abundance in T-47D human breast cancer cells. Molec. Endocr. 3 (1989) 611-616.
104. Mueller S. G., Kobrin M. S., Paterson A. J. and Kudlow J. E.: Transforming growth factor-α expression in the anterior pituitary gland: regulation by epidermal growth factor and phorbol ester in dispersed cells. Molec. Endocr. 6 (1989) 976-983.
105. Pittelkow M. R., Lindquist P. B., Abraham R. T., Graves-Deal R., Derynck R. and Coffey R. J.: Induction of transforming growth factor-α expression in human keratinocytes by phorbol esters. J. Biol. Chem. 264 (1989) 5164-5171.
106. Bjorge J. D., Paterson A. J. and Kudlow J. E.: Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-α in a breast cancer cell line. J. Biol. Chem. 264 (1989) 4021-4027.
107. Kudlow J. E. and Bjorge J. D.: TGF-α in normal physiology. Sem. Cancer Biol. 1 (1990) 293-302.
108. Shoyab M., Plowman G. D., McDonald V. L., Bradley J. G. and Todaro G. J.: Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 243 (1989) 1074-1076.
109. erbB2. J. Biol. Chem. 268 (1993) 2924-2931.
110. Shoyab M., McDonald V. L., Bradley J. G. and Todaro G. J.: Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc. Natn. Acad. Sci. U.S.A. 85 (1988) 6528-6532.
111. Johnson G. R., Saeki T., Auersperg N., Gordon A. W., Shoyab M., Salomon D. S. and Stromberg K.: Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin. Biochem. Biophys. Res. Commun. 180 (1991) 481-488.
112. Johnson G. R., Saeki T., Gordon A. W., Shoyab M., Salomon D. S and Stromberg K.: Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J. Cell Biol. 118 (1992) 741-751.
113. Cook P. W., Mattox P. A., Keeble W. W., Pittelkow M. R., Plowman G. D., Shoyab M., Adelman J. P. and Shipley G. D.: A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Molec. Cell Biol. 11 (1991) 2547-2557.
114. Normanno N., Selvam M. P., Qi C. -F., Saeki T., Johnson G, Kim N., Ciaridello F., Shoyab M., Plowman G., Brandt R., Todaro G. and Salomon D. S.: Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 2790-2794.
115. Plowman G. D., Green J. M., McDonald V. L., Neubauer M. G., Disteche C. M., Todaro G. J. and Shoyab M.: The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor inhibitor activity. Molec. Cell Biol. 10 (1990) 1969-1981.
116. Saeki T., Stromberg K., Qi C. -F., Gullick W., Tahara E., Normanno N., Ciardello F., Kenney N., Johnson G. R. and Salomon D. S.: Differential immunohistochemical localization of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res. 52 (1991) 3467-3473.
117. Cook P. W., Pittelkow M. R., Keeble W. W., Graves-Deal R., Coffey R. J. Jr. and Shipley G. D.: Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res. 52 (1992) 3224-3227.
118. Normanno N., Qi C. -F., Gullick W. J., Persico G., Yarden Y., Wen D., Plowman G., Kenney N., Johnson G., Kim N., Brandt R., Martinez-Lacaci I., Dickson R. B. and Salomon D. S.: Expression of amphioregulin, critpo-1, and heregulin a in human breast cancer cells. Int. J. Oncol. 2 (1993) 903-911.
119. Kimura H.: Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 2165-2169.
120. Modrell B., McDonald V. L. and Shoyab M.: The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins. Growth Factors 1 (1992) 305-314.
121. Li S., PLowman G. D., Buckley S. D. and Shipley G. D.: Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J. Cell Physiol. 153 (1992) 103-111.
122. Piepkorn M., Lo C. and Plowman G. D.: Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J. Cell Physiol. 159 (1994) 114-120.
123. Johnson G. R. and Wong L.: Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J. Biol. Chem. 269 (1994) 27,149-27,154.
124. Thorne B.A. and Plowman G. D.: The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion. Molec. Cell Biol. 14 (1994) 1635-1646.
125. Johnson G. R., Prigent S. A., Gullik W. J. and Stromberg K.: Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. J. Biol. Chem. 268 (1993) 18,835-18,843.
126. Martinez-Lacaci I., Saceda M., Plowman G. D., Johnson G. R., Normann N., Salomon D. S. and Dickson R. B.: Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cells. Endocrinology 136 (1995) 3983-3992.
127. Darbon J. -M., Valette A. and Bayard F.: Phorbol esters inhibit the proliferation of MCF-7 cells. Biochem. Pharmac. 35 (1986) 2683-2686.
128. 2+-dependent protein kinase in human breast cancer cells Int. J. Cancer 37, 731-737.
129. Higashiyama S., Abraham J. A., Miller J., Fiddes J. C. and Klagsbrun M.: A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251 (1991) 936-939.
130. Marikovsky M., Breuing K., Liu P. Y., Eriksson E., Higashiyama S., Farber P., Abraham. J. and Klagsbrun M.: Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 3889-3893.
131. Yoshizumi M., Kourembanas S., Temizer D. H., Cambria R. P., Quertermous T. and Lee M. -E.: Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor gene in vascular endothelial cells. J. Biol. Chem. 267 (1992) 9467-9469.
132. Temizer D. H., Yoshizumi M., Perrella M. A., Susanni E. E., Quertermous T., and Lee M. -E.: Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol Chem. 267 (1992) 24,892-24,896.
133. Dluz S. M., Higasiyama S., Damm D., Abraham J. A. and Klagsbrun M.: Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. J. Biol. Chem. 268 (1993) 18,330-18,334.
134. Zhang Z., Funk C., Roy D., Glasser S. and Mulholland J.: Heparin-binding epidermal growth factor-like growth factor is differentially regulated by progesterone and estradiol in rat uterine epithelial and stromal cells. Endocrinology 134 (1994) 1089-1094.
135. Normanno N., Ciardiello F., Brandt R. and Salomon D. S.: Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res. Treat. 29 (1994) 11-27.
136. Carraway K. L. III, Sliwkowski M. X., Akita R., Platko J. V., Guy P. M., Nuijens A., Diamonti A. J., Vandlen R. L., Cantley L. C. and Cerione R. A.: The erbB3 gene product is a receptor for heregulin. J. Biol. Chem. 269 (1994) 14,303-14,306.
137. Murphy L. J.: Growth factors and steroid hormone action in endometrial cancer. J. Steroid Biochem. Molec. Biol. 48 (1994) 419-423.
138. Reynolds R. K., Talavera F., Roberts J. A., Hopkins M. P. and Menon K. M. J.: Regulation of epidermal growth factor and insulin-like growth factor I receptors by estradiol and progesterone in normal and endometrial cell cultures. Gynec. Oncol. 38 (1990) 396-406.
139. DiAugustine R. P., Petrusz P., Bell G. I., Brown C. F., Korach K. S., McLachlan J. A. and Tebg C. T.: Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messanger ribonucleic acid. Endocrinology 122 (1988) 2355-2363.
140. Zhang Z., Funk C., Roy D., Glasser S. and Mulholland J.: Heparin-binding epidermal growth factor-like growth factor is differentially regulated by progesterone and estradiol in rat uterine epithelial and stromal cells. Endocrinology 134 (1994) 1089-1094.
141. Steiner M. S.: Role of peptide growth factors in the prostate: a review. Urology 42 (1993) 99-110.
142. Connolly J. M. and Rose D. P.: Production of epidermal growth factor and transforming growth factor-α by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16 (1990) 209-218.
143. Ware J. L.: Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev. 12 (1993) 287-301.
144. Liu X. -H., Wiley H. S. and Meikle A. W.: Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-α (TGF-α) and epidermal growth factor (EGF) / TGF-α receptor. J. Clin. Endocr. Metab. 77 (1993) 1472-1478.
145. Seghal I., Bailey J., Hitzemann K., Pittelkow M. R. and Maihle N. J.: Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells. Molec Biol. Cell 5 (1994) 339-347.